Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Urologic oncology")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 791

  • Page / 32
Export

Selection :

  • and

13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cellsTIANXIN LIN; XINBAO YIN; QINGQING CAI et al.Urologic oncology. 2012, Vol 30, Num 3, pp 339-345, issn 1078-1439, 7 p.Article

An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell linesJINGJING YOU; MADIGAN, Michele C; ROWE, Alexandra et al.Urologic oncology. 2012, Vol 30, Num 4, pp 502-508, issn 1078-1439, 7 p.Article

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?RAJU KUMAR MANDAL; RAMA DEVI MITTAL.Urologic oncology. 2012, Vol 30, Num 5, pp 555-561, issn 1078-1439, 7 p.Article

Clinical characteristics of bladder urothelial tumors in male patients—the influences of benign prostatic hyperplasia/benign prostatic enlargementZHANG, Nian-Zhao; JUN CHEN; LIN MA et al.Urologic oncology. 2012, Vol 30, Num 5, pp 646-651, issn 1078-1439, 6 p.Article

Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: A prospective single-center studySCHLENKER, Boris; SCHER, Bernhard; STIEF, Christian G et al.Urologic oncology. 2012, Vol 30, Num 1, pp 55-59, issn 1078-1439, 5 p.Article

Environmental and modifiable risk factors in renal cell carcinoma : Environmental Exposures and Genitourinary MalignanciesNAVAI, Neema; WOOD, Christopher G.Urologic oncology. 2012, Vol 30, Num 2, pp 220-224, issn 1078-1439, 5 p.Article

Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancerHARA, Noboru; TAKIZAWA, Itsuhiro; ISAHAYA, Etsuko et al.Urologic oncology. 2012, Vol 30, Num 5, pp 596-601, issn 1078-1439, 6 p.Article

Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planningMATZKIN, Haim; CHEN, Juza; STENGER, Amira et al.Urologic oncology. 2012, Vol 30, Num 4, pp 379-385, issn 1078-1439, 7 p.Article

Prostate biopsy in patients with long-term use of indwelling bladder catheter: What is the rationale?ANTUNES, Alberto A; BARBOSA, Joao Arthur B. A; REIS, Sabrina T et al.Urologic oncology. 2012, Vol 30, Num 5, pp 620-623, issn 1078-1439, 4 p.Article

Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physiciansTASIAN, Gregory E; COOPERBERG, Matthew R; COWAN, Janet E et al.Urologic oncology. 2012, Vol 30, Num 2, pp 155-160, issn 1078-1439, 6 p.Article

Renal cell carcinoma with metastases to the gallbladder: Four cases from the National Cancer Institute (NCI) and review of the literatureCHUNG, Paul H; SRINIVASAN, Ramaprasad; MARSTON LINEHAN, W et al.Urologic oncology. 2012, Vol 30, Num 4, pp 476-481, issn 1078-1439, 6 p.Article

Subepithelial growth patterns in urothelial carcinoma—frequency and prognostic significanceGOFRIT, Ofer N; SHAPIRO, Amos; PODE, Dov et al.Urologic oncology. 2012, Vol 30, Num 1, pp 49-54, issn 1078-1439, 6 p.Article

Testicular cancer: A narrative review of the role of socioeconomic position from risk to survivorship : Impact of Poverty and Race-Ethnicity on Treatment and Management of Urologic CancersRICHARDSON, Lisa C; NERI, Antonio J; TAI, Eric et al.Urologic oncology. 2012, Vol 30, Num 1, pp 95-101, issn 1078-1439, 7 p.Article

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center studyBALDAZZI, Valentina; TASSI, Renato; LAPINI, Alberto et al.Urologic oncology. 2012, Vol 30, Num 5, pp 704-710, issn 1078-1439, 7 p.Article

The multi-disciplinary management of high-risk prostate cancerPICARD, Jonathan C; GOLSHAYAN, Ali-Reza; MARSHALL, David T et al.Urologic oncology. 2012, Vol 30, Num 1, pp 3-15, issn 1078-1439, 13 p.Article

The predominance of benign histology in small testicular massesSHILO, Yaniv; ZISMAN, Amnon; LINDNER, Arie et al.Urologic oncology. 2012, Vol 30, Num 5, pp 719-722, issn 1078-1439, 4 p.Article

Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodesROSEVEAR, Henry M; WILLIAMS, Hadyn; COLLINS, Matthew et al.Urologic oncology. 2012, Vol 30, Num 5, pp 723-726, issn 1078-1439, 4 p.Article

mTOR pathway inhibition in renal cell carcinomaPINTO MARIN, Alvaro; REDONDO SANCHEZ, Andrés; ESPINOSA ARRANZ, Enrique et al.Urologic oncology. 2012, Vol 30, Num 4, pp 356-361, issn 1078-1439, 6 p.Article

Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?KATZ, Betina; SROUGI, Miguel; DALL'OGLIO, Marcos et al.Urologic oncology. 2012, Vol 30, Num 6, pp 794-797, issn 1078-1439, 4 p.Article

Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South EgyptWOLPERT, Beverly J; AMR, Sania; ZHENG, Yun-Ling et al.Urologic oncology. 2012, Vol 30, Num 6, pp 841-847, issn 1078-1439, 7 p.Article

Does body mass index have an impact on the rate and location of positive surgical margins following robot assisted radical prostatectomy?ZILBERMAN, Dorit E; TSIVIAN, Matvey; YONG, Daniel et al.Urologic oncology. 2012, Vol 30, Num 6, pp 790-793, issn 1078-1439, 4 p.Article

Expression of Medl9 in bladder cancer tissues and its role on bladder cancer cell growthHU ZHANG; HAOWEN JIANG; WEI WANG et al.Urologic oncology. 2012, Vol 30, Num 6, pp 920-927, issn 1078-1439, 8 p.Article

Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladderDUBOSQ, Francis; PLOUSSARD, Guillaume; SOLIMAN, Hany et al.Urologic oncology. 2012, Vol 30, Num 6, pp 833-840, issn 1078-1439, 8 p.Article

Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC)PANTELIADOU, Marianthi; GIATROMANOLAKI, Alexandra; TOULOUPIDIS, Stavros et al.Urologic oncology. 2012, Vol 30, Num 6, pp 813-820, issn 1078-1439, 8 p.Article

Life after failure of traditional androgen deprivation therapySCHELLHAMMER, Paul.Urologic oncology. 2012, Vol 30, Num 4, issn 1078-1439, S10-S14, SUPConference Paper

  • Page / 32